|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Effects
of Terminalia catappa seeds on sexual behaviour and fertility of male
rats
W.
D. Ratnasooriya, M. G. Dharmasiri Department
of Zoology, University of Colombo, Colombo 3, Sri Lanka Asian J Androl 2000 Sep; 2: 213-219 Keywords:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
Vehicle
(1% methyl cellulose) |
SS
1500 mg/kg |
SS
3000 mg/kg |
| %
mounted |
100 |
100 |
83.3c |
| %
intromitted |
100 |
100 |
83.3c |
| %
ejaculated |
100 |
100 |
33.3c |
| Number
of mounts |
12.80.8 |
15.30.6 |
11.62.3 |
| Number
of |
12.80.8 |
15.30.6 |
11.62.3 |
| Mount
latency (s) |
17.84.5 |
36.60.6c |
270.585.2c |
| Intromission |
17.84.5 |
36.60.6c |
270.585.2c |
| Ejaculation |
525.031.4 |
622.531.1b |
865.020.8c |
| Copulatory
efficiency |
100 |
100 |
100 |
| Intercopulatory |
41.51.7 |
41.83.3 |
63.013.8b |
bP<0.05,
cP<0.01, compared with controls
(Mann-Whitney U-test
and G-test).
3.3
Male fertility
The
high dose of SS provoked a qualitative impairment of precoital sexual
behaviour on days 1, 3 and 7 of treatment.
However, pre-coital sexual behaviour of these rats was essentially
comparable to that of control rats on day 7 posttreatment.
In
contrast, none of the fertility parameters was significantly altered (Table
2) except for ejaculated sperm counts which were moderately but not significantly
increased (day 1 by 167%, day 4 by 7%, and day 7 by 60%).
Table
2. Effect of 7-day oral administration 3000 mg/kg of seed kernel suspension
(SS) of T. catappa on some fertility parameters of male rats (meanSEM,
n=6, ranges in parentheses).
| |
|
Treatment |
Post-treatment |
||
| Day
1 |
Day
4 |
Day
7 |
Day
7 |
||
|
Index
of |
Vehicle |
100 |
100 |
100 |
100 |
| SS |
100 |
100 |
100 |
100 |
|
|
Vaginal
perm |
Vehicle |
10.83.3 |
8.01.7 |
9.40.8 |
9.22.6 |
| SS |
28.88.4 |
8.52.1 |
15.02.8 |
9.12.8 |
|
|
Quantal
pregnancy (%) |
Vehicle |
100 |
100 |
100 |
100 |
| SS |
100 |
100 |
100 |
100 |
|
|
Fertility
index (%) |
Vehicle |
100 |
100 |
100 |
100 |
| SS |
100 |
100 |
100 |
100 |
|
|
Implantation
index (%) |
Vehicle |
916.7 |
1016.7 |
950.0 |
900.0 |
| SS |
950.0 |
833.3 |
1000.0 |
916.7 |
|
|
Number
of implants |
Vehicle |
9.20.5 |
10.20.5 |
9.50.4 |
9.00.5 |
| SS |
10.01.6 |
8.30.5 |
10.00.6 |
9.21.1 |
|
|
Pre-implantation
loss (%) |
Vehicle |
13.82.5 |
19.34.9 |
19.94.1 |
14.32.3 |
| SS |
10.41.3 |
10.12.3 |
12.33.2 |
13.52.4 |
|
|
Post-implantation
loss (%) |
Vehicle |
0.0 |
0.0 |
0.0 |
0.0 |
| SS |
0.0 |
0.0 |
0.0 |
0.0 |
|
3.4
Morphology and wet weights of accessory organs
Treatment
with high dose of SS, for 7 days, had no effect on the size and the appearance
of testes, excurrent ducts, or sexual accessory glands.
Further, their wet
weights were not altered (control vs treatment: testes, 936.718.9 vs
886.725.7; epididymis, 323.312.0 vs 340.05.8; vas deferens, 70.25.1
vs 74.02.3; seminal vesicle and coagulatory gland complex, 823.350.4
vs 836.739.2 and lateral prostate, 240.014.6 vs 253.319.4 mg/100
g body weight).
3.5
Haematology
Of
the nine blood parameters monitored in these rats, on day 1 post-treatment, none
was significantly altered by the high dose of SS (control vs treatment):
RBC count (5.970.15 vs 5.470.08106 cells/mm3),
WBC count (181261611 vs 216831270
cell/mm3); PCV (47.3%0.8% vs 47.0%0.6%); haemoglobin content
(16.20.4 vs 16.80.4 g/dL); and DC (neutrophils: 45.0%0.9% vs 21.5%2.5%,
lymphocytes: 52.4%0.7% vs 76.9%2.2%, eosinophils:
0.6%0.2% vs 0.0%0.0%, monocytes: 2.0%0.2% vs 1.3%0.2% and
basophils 0.0%0.0% vs 0.0%0.0%).
3.6
Sedative effect
As
shown in Table 3, in the rat hole-board experiment, a 750 mg/kg dose of
SS did not alter any of the parameters monitored whilst a dose of 1500
mg/kg inhibited 3 parameters: number of rears (by 41%: P<0.05
), locomotor activity (by 45%: P<0.01) and number of head dips
(by 42%: P<0.05).
On the other hand, with the highest dose, only 2 parameters were
significantly inhibited: number of rears (by 62%; P<0.01) and
locomotor activity (by 69%; P<0.01).
The
EC50 values for the impairment of number of rears and locomotory
activity were 1313.5
and 1311.6 mg/kg, respectively.
Linear regression analysis was used to investigate the dose-response
relationships in the rat-hole board technique.
There was a highly significant relationship only between the doses
and locomotory activity (r2 = 0.96; P<0.01).
Table
3. Effects of oral administration of different concentrations of seed
kernel suspension (SS) of T. catappa on the parameters of rat hole-board
technique (meanSEM,
n=12, ranges in parentheses).
|
|
Number |
Number
of |
Time/ |
Locomotor |
Number
of |
| Vehicle
(1% methyl cellulose) |
19.71.7 |
6.10.8 |
1.00.2 |
18.02.1 |
4.30.9 |
| SS
750 mg/kg |
20.12.7 |
4.80.9 |
1.10.2 |
14.51.2 |
7.30.8 |
| SS
1500 mg/kg |
11.62.4b |
3.50.9b |
1.10.1 |
9.91.9c |
3.70.9 |
| SS
3000 mg/kg |
7.51.3c |
4.40.8 |
0.80.2 |
5.70.9c |
3.90.8 |
As
compared with controls: bP<0.05, cP<0.01
(Mann-Whitney U-test).
3.7
Muscle relaxation and muscle coordination
At
3 h post-treatment, the high dose of the SS failed to alter the latency
to fall significantly in the bar holding test (control vs treatment: 51.442.98
vs 50.562.52 sec)
and the latency to slide off in the Bridge test (control vs treatment:
45.004.24 vs 46.004.08 sec).
3.8
Analgesic effect
The
high dose of SS failed to alter the reaction times significantly 3 and
6 h post-treatment
when evaluated both by the tail flick (control vs treatment at
3 h, 3.20.3 vs 3.40.5 sec and at 6 h, 2.70.2 vs 3.70.3 sec) and
hot plate (control vs treatment: at 3 h, 13.931.05 vs 16.581.72 sec
and at 6 h, 11.480.57
vs 15.652.80 sec) techniques.
3.9
Hypoglycaemic effect
The
high dose of SS had no effect on the fasting blood glucose level 3 h post
treatment (data not shown). The high dose of SS also had no effect on
the fasting blood glucose level 3 h post treatment (control vs treatment:
75.53.2 vs 83.46.9
mg/dL, P>0.05).
3.10
Liver toxicity
Seven
day treatment of high dose of SS caused significant elevations in both
SGOT (by 34%) (control vs treatment: 57.56.6 vs 77.35.6 U/L; P<0.05)
and SGPT (by 73% ) (control vs treatment: 17.51.4 vs 30.3 vs 5.1 U/L;
P<0.01). In contrast,
with the lower dose there was no significant change in either of these
enzyme activities SGOT (control vs treatment: 57.56.6 vs 43.310.3
U/L) or SGPT (control vs treatment: 17.51.4 vs 20.23.5 U/L) level.
3.11
Other adverse effects
There
were neither treatment-related defects nor overt clinical signs of toxicity,
stress or changes in behaviour and appearance evident.
4
Discussion
At
the doses tested, SS of T. catappa had no effect on orgasm or immediate fertility
but caused marked changes in the male sexual behaviour.
The nature and severity of these demasculinisation effects, however,
differed according to the dose used;
the lower dose impaired sexual arousability whilst the higher dose
in addition, decreased sexual performance, sexual interest and libido.
Irrespective of
the dose these inhibitory effects on sexual behaviour had a rapid onset
and recovery.
Collectively,
these data suggest a receptor-mediated action in the brain[10].
Alkaloids and aminoacids
are present in the SS of T. catappa and these can inhibit male sexual
behaviour of rats[10,11] in a similar fashion, as was evident
in this study, through
cholinergic and serotonergic receptors.
Subchronic treatment of high dose of SS caused moderate elevations
in SGOT and SGPT activity indicating liver toxicity. This is a matter
for concern. However, liver toxicity was not elicited with the lower dose.
However,
other than this effect on the liver, there were no overt signs of general
toxicity, haemotoxicity, motor deficiencies, motor incoordination, general
lethargy, behavioural abnormalities, stress or a lowering of body weight
and suppression of food intake.
Thus,
the antimasculine effects of SS can not be a consequence of generalised
toxic effects but is due to a selective action.
With the lower dose only the time required for treated rats to
mount, intromit or ejaculate was greatly prolonged whilst the other sexual
parameters remained unchanged.
Taken together, the prolongation of these three latencies suggest
a reduction in sexual arousability/motivation: as an inverse relationship
exists between these three parameters of male sexual behaviour and sexual
arousal/motivation[12].
On
the other hand, the prolongation of the ejaculatory latency by itself
suggests an aphrodisiac action.
All the treated rats mounted and intromitted without any
inhibition of mount-and-intromission frequencies or copulatory efficiency or
intercopulatory interval.
This suggests that libido, sexual vigour and sexual performance
were unimpaired during the aphrodisiac action.
A
similar effect on copulatory behaviour of rats is reported with a water
extract of Piper betel leaves[13].
Further, the nonimpairment in the number of rats attempting intromission
and in the number of intromissions made strongly suggests that the lower
dose does not disrupt penile erectile function: in the rat, anteroflexions
or flips are essential for penile insertion during copulation[14].
The inability of the SS to prolong the reaction times in the tail
flick and hot plate techniques suggest that the aphrodisiac action is
not mediated via an impairment of penile sensitivity resulting from analgesia.
Nevertheless, SS induced elevation in threshold of cutaneous penile
receptors cannot be ruled out.
The
higher dose of SS, on the other hand, impaired all the parameters of sexual
behaviour other than mounting-and-intromission frequency and copulatory
efficiency indicating that sexual vigour remained uninhibited.
However, the anti-libido effect, at this dose, would reduce the
aphrodisiac value of T. catappa seeds.
The rapid onset and reversibility of the sexual behavioural changes
as well as the lack
of a significant change in either the absolute or relative weights of
sexual accessory organs and unimpaired index of libido strongly suggest
that the anti-libido effect is not mediated through a change in the blood
testosterone level.
Hyperprolactenaemia
in males causes deterioration of their sexual behaviour and libido[15].
However, this mechanism seems unlikely to be operative in this
study because it is generally accepted that only long-term hyperprolactenaemia
can induce deficient sexual behaviour[16].
Here, sexual behaviour was inhibited as early as 3 h of treatment.
Sedatives inhibit libido and sexual performance[17]. The SS showed a sedative activity in a dose related manner as judged by the inhibition of three of the four parameters in the rat hole-board technique. Thus sedative activity of the SS can account for the observed impairments of sexual behaviour and libido. The failure of the SS to alter latencies of bar holding and Bridge tests provides further support to this notion: as false positive results are evident in rat hole-board technique by muscle deficiencies and their incoordinations. The SS had no hypoglycaemic activity, thus, the sedation is unlikely to be mediated through a reduction in blood glucose level.
In conclusion, the present findings show that seeds of T. catappa possess potent aphrodisiac activity and provides scientific evidence in favour of the claims made in Ayurvedic medicine in Sri Lanka regarding this action. The results also suggest that moderate consumption of kernel of seed of T. catappa could be useful in the treatment of men with sexual dysfunctions resulting primarily from premature ejaculation.
References
[1]
Jayasinghe DM. Ayurveda
Pharmacopoeia Colombo. Sri Lanka: Department of
Ayurveda; 1997. p 67-8.
[2] Chandrasena MM. In:
Weragoda PB, editor. Osuturu
Wisitutru, Part III, Colombo,
Sri Lanka: Department of Ayurveda; 1994. p 5-6.
[3] Griffin PD. In: Diczfalusy
E, Griffin PD, Khanna J, editors. Research in Human Reproduction.
World Health Organization, Geneva, Switzerland; 1988.
[4] Farnsworth NR. Biological
and Phytochemical screening of plants.
J Pharmaceutical Sci 1996; 55: 225-76.
[5] Cheesbrough M, McArthur J.
A Laboratory Mannual for Rural Tropical Hospitals.
New York: Churchill Livingstone; 1976.
[6] File SE, Wardill A.
Validity of head-dipping as a measure of exploration in
modified hole-board.
Psychopharmacology 1975; 44: 53-7.
[7] Plaznik A, Stefanski R, Palejko W, Kotawski W.
The role of accumbens GABAB
receptors in the regulation of rat behaviour.
Neurosci Res Comm 1993; 12: 23-30.
[8] Langerman L, Zakouski MI, Piskown B, Grant GJ.
Hot plate versus tailflick: evaluation of acute tolerence to continuous
morphine infusion in the rat model. J Pharmacol Toxicol Methods 1995;
34: 23-8.
[9] Furtuoso VS, Gurjao MRR, Cordeiro RSB, Martins MA. Analgesic and
antiulcerogenic effects of a polar extract from the leaves of Vernonia
condensata. Planta Medica
1994; 60: 21-4.
[10] Fernandez-Guasti A, Escalante AL, Ahlenius S, Hillegaart V, Larson
K. Stimulation of
5-HT1A and 5-HT1B receptors in brain regions
and its effects on male rat
sexual behaviour.
Eur J Pharmacol 1992; 210: 121-9.
[11] Retana-Marquez S, Salazar ED, Velazquez-Moctezuma J. Muscarinic
and nicotinic influences
on masculine sexual behaviour in rats: Effects of Oxotremorine,
Scopolamine, and Nicotine.
Pharmacol Biochem Behav 1993; 44: 913-7.
[12] Benelli A, Artetti R, Poggioli R, Cavazzuti E, Mameli M, Bertolini
A. Effect of
potassium channel modulators on male sexual behaviour.
Life Sci 1997; 60; 263-7.
[13] Ratnasooriya WD, Premakumara GAS.
Piper betle leaves impairs musculine
sexual behaviour of rats.
Med Sci Res 1996; 24: 303-6.
[14] Holmes GM, Chapple WD, Leipheimer RE, Sachs BD.
Electromyographic analysis of male rat perineal muscles during
copulation and reflexive erections.
Physiol Behav 1991; 49: 1235-46.
[15] Chambers KC, Phoenix CH.
Sexual behaviour and serum level of prolactin, testosterone and
oestradiol in young and old Rhesus males. Physiol Behav 1992; 52:13-6.
[16] Bartke A, Smith MS, Michael SD, Person FG, Darkterio S.
Effects of experimentally induced chronic hyperprolactinemia on
testosterone and gonadotropin levels in male rats and mice. J Endocrinol
1997; 49: 311-6.
[17] Horowitz JD, Globle AJ.
Drugs and impaired male sexual function. Drugs
1979; 18: 206-17.
Correspondence
to: Professor
W. D. Ratnasooriya, Department of Zoology,
University of Colombo, Colombo 03, Sri Lanka.
e-mail:
dappvr@sltnet.lk
Received
2000-05-30 Accepted 2000-07-25
